nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—ADRB3—Timolol—migraine	0.104	0.264	CbGbCtD
Nadolol—Levobunolol—Timolol—migraine	0.0996	0.224	CrCrCtD
Nadolol—ADRB3—Propranolol—migraine	0.0928	0.236	CbGbCtD
Nadolol—Penbutolol—Timolol—migraine	0.0906	0.203	CrCrCtD
Nadolol—Bupranolol—Timolol—migraine	0.072	0.162	CrCrCtD
Nadolol—Carteolol—Propranolol—migraine	0.053	0.119	CrCrCtD
Nadolol—Levobunolol—Propranolol—migraine	0.053	0.119	CrCrCtD
Nadolol—Penbutolol—Propranolol—migraine	0.0482	0.108	CrCrCtD
Nadolol—ADRB2—Timolol—migraine	0.0426	0.108	CbGbCtD
Nadolol—ADRB1—Timolol—migraine	0.0419	0.106	CbGbCtD
Nadolol—ADRB2—Propranolol—migraine	0.0379	0.0964	CbGbCtD
Nadolol—ADRB1—Propranolol—migraine	0.0374	0.0949	CbGbCtD
Nadolol—Pindolol—Propranolol—migraine	0.029	0.0651	CrCrCtD
Nadolol—ABCB1—Timolol—migraine	0.0113	0.0288	CbGbCtD
Nadolol—ABCB1—Propranolol—migraine	0.0101	0.0256	CbGbCtD
Nadolol—ABCB1—Amitriptyline—migraine	0.00873	0.0222	CbGbCtD
Nadolol—ABCB1—Verapamil—migraine	0.00693	0.0176	CbGbCtD
Nadolol—Penbutolol—HTR1B—migraine	0.000692	0.324	CrCbGaD
Nadolol—Penbutolol—HTR1A—migraine	0.000548	0.257	CrCbGaD
Nadolol—Pindolol—HTR1B—migraine	0.000499	0.234	CrCbGaD
Nadolol—Pindolol—HTR1A—migraine	0.000395	0.185	CrCbGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000242	0.00501	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—RAMP1—migraine	0.000234	0.00484	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CALCRL—migraine	0.000234	0.00484	CbGpPWpGaD
Nadolol—ADRB1—Amine ligand-binding receptors—HTR2A—migraine	0.000233	0.00481	CbGpPWpGaD
Nadolol—ADRB3—G alpha (s) signalling events—HTR7—migraine	0.000231	0.00478	CbGpPWpGaD
Nadolol—ADRB2—Amine ligand-binding receptors—HTR2A—migraine	0.000228	0.00471	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000223	0.00461	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000207	0.00429	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Other—EDNRA—migraine	0.000191	0.00394	CbGpPWpGaD
Nadolol—Hyperhidrosis—Amitriptyline—migraine	0.00019	0.00172	CcSEcCtD
Nadolol—Libido decreased—Gabapentin—migraine	0.00019	0.00172	CcSEcCtD
Nadolol—Diplopia—Timolol—migraine	0.000189	0.00171	CcSEcCtD
Nadolol—Dry eye—Topiramate—migraine	0.000188	0.0017	CcSEcCtD
Nadolol—Disturbance in sexual arousal—Timolol—migraine	0.000187	0.0017	CcSEcCtD
Nadolol—Amnesia—Gabapentin—migraine	0.000187	0.00169	CcSEcCtD
Nadolol—Anorexia—Amitriptyline—migraine	0.000187	0.00169	CcSEcCtD
Nadolol—Affect lability—Timolol—migraine	0.000186	0.00168	CcSEcCtD
Nadolol—Hypotension—Amitriptyline—migraine	0.000183	0.00166	CcSEcCtD
Nadolol—Alopecia—Verapamil—migraine	0.000183	0.00166	CcSEcCtD
Nadolol—Cardiac failure—Gabapentin—migraine	0.00018	0.00163	CcSEcCtD
Nadolol—Lethargy—Gabapentin—migraine	0.000179	0.00162	CcSEcCtD
Nadolol—Mood swings—Timolol—migraine	0.000179	0.00162	CcSEcCtD
Nadolol—Insomnia—Amitriptyline—migraine	0.000177	0.00161	CcSEcCtD
Nadolol—Paraesthesia—Amitriptyline—migraine	0.000176	0.0016	CcSEcCtD
Nadolol—Diplopia—Gabapentin—migraine	0.000176	0.00159	CcSEcCtD
Nadolol—Abdominal discomfort—Valproic Acid—migraine	0.000176	0.00159	CcSEcCtD
Nadolol—Disturbance in sexual arousal—Gabapentin—migraine	0.000174	0.00158	CcSEcCtD
Nadolol—Affect lability—Gabapentin—migraine	0.000173	0.00157	CcSEcCtD
Nadolol—Dyspepsia—Amitriptyline—migraine	0.000173	0.00156	CcSEcCtD
Nadolol—ADRB2—GPCRs, Other—HTR7—migraine	0.000172	0.00355	CbGpPWpGaD
Nadolol—Cough—Propranolol—migraine	0.000171	0.00155	CcSEcCtD
Nadolol—Sleep disorder—Topiramate—migraine	0.000171	0.00155	CcSEcCtD
Nadolol—Decreased appetite—Amitriptyline—migraine	0.000171	0.00154	CcSEcCtD
Nadolol—ADRB3—GPCR ligand binding—HTR1D—migraine	0.00017	0.00351	CbGpPWpGaD
Nadolol—Vision blurred—Verapamil—migraine	0.00017	0.00154	CcSEcCtD
Nadolol—Fatigue—Amitriptyline—migraine	0.000169	0.00153	CcSEcCtD
Nadolol—Constipation—Amitriptyline—migraine	0.000168	0.00152	CcSEcCtD
Nadolol—Irritability—Gabapentin—migraine	0.000168	0.00152	CcSEcCtD
Nadolol—Weight increased—Valproic Acid—migraine	0.000167	0.00151	CcSEcCtD
Nadolol—Mood swings—Gabapentin—migraine	0.000166	0.00151	CcSEcCtD
Nadolol—Disorientation—Topiramate—migraine	0.000165	0.0015	CcSEcCtD
Nadolol—Depression—Valproic Acid—migraine	0.000163	0.00148	CcSEcCtD
Nadolol—Nasal congestion—Topiramate—migraine	0.000162	0.00147	CcSEcCtD
Nadolol—Syncope—Verapamil—migraine	0.000161	0.00146	CcSEcCtD
Nadolol—Dry skin—Gabapentin—migraine	0.000161	0.00146	CcSEcCtD
Nadolol—Bronchospasm—Timolol—migraine	0.00016	0.00145	CcSEcCtD
Nadolol—ADRB1—G alpha (s) signalling events—NPS—migraine	0.00016	0.0033	CbGpPWpGaD
Nadolol—Libido decreased—Topiramate—migraine	0.000159	0.00144	CcSEcCtD
Nadolol—Conjunctivitis—Valproic Acid—migraine	0.000159	0.00144	CcSEcCtD
Nadolol—Loss of consciousness—Verapamil—migraine	0.000158	0.00143	CcSEcCtD
Nadolol—ADRB3—GPCR ligand binding—HTR2B—migraine	0.000158	0.00327	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000158	0.00326	CbGpPWpGaD
Nadolol—Amnesia—Topiramate—migraine	0.000157	0.00143	CcSEcCtD
Nadolol—Sweating—Valproic Acid—migraine	0.000157	0.00142	CcSEcCtD
Nadolol—ADRB2—G alpha (s) signalling events—NPS—migraine	0.000156	0.00323	CbGpPWpGaD
Nadolol—Visual disturbance—Topiramate—migraine	0.000156	0.00141	CcSEcCtD
Nadolol—Gastritis—Gabapentin—migraine	0.000156	0.00141	CcSEcCtD
Nadolol—Hypertension—Verapamil—migraine	0.000155	0.00141	CcSEcCtD
Nadolol—Body temperature increased—Amitriptyline—migraine	0.000155	0.0014	CcSEcCtD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000155	0.0032	CbGpPWpGaD
Nadolol—Chest pain—Verapamil—migraine	0.000153	0.00139	CcSEcCtD
Nadolol—Agranulocytosis—Valproic Acid—migraine	0.000152	0.00138	CcSEcCtD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000152	0.00314	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000151	0.00313	CbGpPWpGaD
Nadolol—Lethargy—Topiramate—migraine	0.000151	0.00137	CcSEcCtD
Nadolol—Erectile dysfunction—Timolol—migraine	0.00015	0.00136	CcSEcCtD
Nadolol—Dry mouth—Verapamil—migraine	0.00015	0.00136	CcSEcCtD
Nadolol—Bronchospasm—Gabapentin—migraine	0.000149	0.00135	CcSEcCtD
Nadolol—Bradycardia—Valproic Acid—migraine	0.000149	0.00135	CcSEcCtD
Nadolol—Diplopia—Topiramate—migraine	0.000148	0.00134	CcSEcCtD
Nadolol—Oedema—Verapamil—migraine	0.000147	0.00133	CcSEcCtD
Nadolol—Disturbance in sexual arousal—Topiramate—migraine	0.000147	0.00133	CcSEcCtD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000147	0.00303	CbGpPWpGaD
Nadolol—ADRB1—G alpha (s) signalling events—CALCA—migraine	0.000147	0.00303	CbGpPWpGaD
Nadolol—Hallucination—Valproic Acid—migraine	0.000146	0.00132	CcSEcCtD
Nadolol—Affect lability—Topiramate—migraine	0.000146	0.00132	CcSEcCtD
Nadolol—Depression—Timolol—migraine	0.000145	0.00131	CcSEcCtD
Nadolol—Shock—Verapamil—migraine	0.000145	0.00131	CcSEcCtD
Nadolol—Insomnia—Propranolol—migraine	0.000144	0.00131	CcSEcCtD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000144	0.00297	CbGpPWpGaD
Nadolol—Paraesthesia—Propranolol—migraine	0.000143	0.0013	CcSEcCtD
Nadolol—ADRB2—G alpha (s) signalling events—CALCA—migraine	0.000143	0.00296	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000143	0.00295	CbGpPWpGaD
Nadolol—Dyspnoea—Propranolol—migraine	0.000142	0.00129	CcSEcCtD
Nadolol—Hyperhidrosis—Verapamil—migraine	0.000142	0.00129	CcSEcCtD
Nadolol—Conjunctivitis—Timolol—migraine	0.000141	0.00128	CcSEcCtD
Nadolol—Visual impairment—Valproic Acid—migraine	0.000141	0.00128	CcSEcCtD
Nadolol—Irritability—Topiramate—migraine	0.000141	0.00128	CcSEcCtD
Nadolol—Asthenia—Amitriptyline—migraine	0.000141	0.00127	CcSEcCtD
Nadolol—Dyspepsia—Propranolol—migraine	0.000141	0.00127	CcSEcCtD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000141	0.00291	CbGpPWpGaD
Nadolol—Mood swings—Topiramate—migraine	0.00014	0.00127	CcSEcCtD
Nadolol—Erectile dysfunction—Gabapentin—migraine	0.00014	0.00127	CcSEcCtD
Nadolol—Sweating—Timolol—migraine	0.000139	0.00126	CcSEcCtD
Nadolol—Decreased appetite—Propranolol—migraine	0.000139	0.00126	CcSEcCtD
Nadolol—Pruritus—Amitriptyline—migraine	0.000139	0.00126	CcSEcCtD
Nadolol—ADRB1—GPCR ligand binding—CALCRL—migraine	0.000139	0.00287	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—RAMP1—migraine	0.000139	0.00287	CbGpPWpGaD
Nadolol—Weight increased—Gabapentin—migraine	0.000138	0.00125	CcSEcCtD
Nadolol—Fatigue—Propranolol—migraine	0.000138	0.00125	CcSEcCtD
Nadolol—Hypotension—Verapamil—migraine	0.000137	0.00124	CcSEcCtD
Nadolol—ADRB1—G alpha (s) signalling events—HTR7—migraine	0.000137	0.00283	CbGpPWpGaD
Nadolol—Tinnitus—Valproic Acid—migraine	0.000137	0.00124	CcSEcCtD
Nadolol—Pain—Propranolol—migraine	0.000137	0.00124	CcSEcCtD
Nadolol—Constipation—Propranolol—migraine	0.000137	0.00124	CcSEcCtD
Nadolol—ADRB2—GPCR ligand binding—RAMP1—migraine	0.000136	0.00281	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CALCRL—migraine	0.000136	0.00281	CbGpPWpGaD
Nadolol—Agranulocytosis—Timolol—migraine	0.000136	0.00123	CcSEcCtD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000135	0.0028	CbGpPWpGaD
Nadolol—Depression—Gabapentin—migraine	0.000135	0.00122	CcSEcCtD
Nadolol—Diarrhoea—Amitriptyline—migraine	0.000134	0.00122	CcSEcCtD
Nadolol—ADRB2—G alpha (s) signalling events—HTR7—migraine	0.000134	0.00277	CbGpPWpGaD
Nadolol—Insomnia—Verapamil—migraine	0.000133	0.0012	CcSEcCtD
Nadolol—Bradycardia—Timolol—migraine	0.000133	0.0012	CcSEcCtD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000132	0.00274	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—RAMP1—migraine	0.000132	0.00273	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CALCRL—migraine	0.000132	0.00273	CbGpPWpGaD
Nadolol—Paraesthesia—Verapamil—migraine	0.000132	0.00119	CcSEcCtD
Nadolol—Conjunctivitis—Gabapentin—migraine	0.000132	0.00119	CcSEcCtD
Nadolol—Dyspnoea—Verapamil—migraine	0.000131	0.00119	CcSEcCtD
Nadolol—Gastritis—Topiramate—migraine	0.000131	0.00118	CcSEcCtD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.00013	0.00269	CbGpPWpGaD
Nadolol—Hallucination—Timolol—migraine	0.00013	0.00118	CcSEcCtD
Nadolol—Sweating—Gabapentin—migraine	0.00013	0.00118	CcSEcCtD
Nadolol—Dizziness—Amitriptyline—migraine	0.00013	0.00117	CcSEcCtD
Nadolol—Alopecia—Valproic Acid—migraine	0.00013	0.00117	CcSEcCtD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00013	0.00268	CbGpPWpGaD
Nadolol—Dyspepsia—Verapamil—migraine	0.000129	0.00117	CcSEcCtD
Nadolol—Abdominal distension—Topiramate—migraine	0.000129	0.00117	CcSEcCtD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000128	0.00266	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000128	0.00265	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000128	0.00265	CbGpPWpGaD
Nadolol—Fatigue—Verapamil—migraine	0.000127	0.00115	CcSEcCtD
Nadolol—Body temperature increased—Propranolol—migraine	0.000126	0.00114	CcSEcCtD
Nadolol—Visual impairment—Timolol—migraine	0.000126	0.00114	CcSEcCtD
Nadolol—Flatulence—Valproic Acid—migraine	0.000126	0.00114	CcSEcCtD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000126	0.0026	CbGpPWpGaD
Nadolol—Pain—Verapamil—migraine	0.000126	0.00114	CcSEcCtD
Nadolol—Constipation—Verapamil—migraine	0.000126	0.00114	CcSEcCtD
Nadolol—Vomiting—Amitriptyline—migraine	0.000125	0.00113	CcSEcCtD
Nadolol—Bradycardia—Gabapentin—migraine	0.000124	0.00112	CcSEcCtD
Nadolol—Rash—Amitriptyline—migraine	0.000124	0.00112	CcSEcCtD
Nadolol—Dermatitis—Amitriptyline—migraine	0.000124	0.00112	CcSEcCtD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000123	0.00255	CbGpPWpGaD
Nadolol—Abdominal discomfort—Topiramate—migraine	0.000123	0.00111	CcSEcCtD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000122	0.00253	CbGpPWpGaD
Nadolol—Tinnitus—Timolol—migraine	0.000122	0.0011	CcSEcCtD
Nadolol—Hallucination—Gabapentin—migraine	0.000121	0.0011	CcSEcCtD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.00012	0.00249	CbGpPWpGaD
Nadolol—Vision blurred—Valproic Acid—migraine	0.00012	0.00109	CcSEcCtD
Nadolol—ADRB2—GPCRs, Other—HTR2A—migraine	0.00012	0.00249	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CALCRL—migraine	0.00012	0.00248	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—RAMP1—migraine	0.00012	0.00248	CbGpPWpGaD
Nadolol—Erectile dysfunction—Topiramate—migraine	0.000118	0.00107	CcSEcCtD
Nadolol—Visual impairment—Gabapentin—migraine	0.000117	0.00106	CcSEcCtD
Nadolol—Nausea—Amitriptyline—migraine	0.000117	0.00106	CcSEcCtD
Nadolol—Weight increased—Topiramate—migraine	0.000116	0.00105	CcSEcCtD
Nadolol—Alopecia—Timolol—migraine	0.000115	0.00104	CcSEcCtD
Nadolol—Asthenia—Propranolol—migraine	0.000115	0.00104	CcSEcCtD
Nadolol—Depression—Topiramate—migraine	0.000114	0.00103	CcSEcCtD
Nadolol—Tinnitus—Gabapentin—migraine	0.000113	0.00103	CcSEcCtD
Nadolol—Cough—Valproic Acid—migraine	0.000111	0.00101	CcSEcCtD
Nadolol—Conjunctivitis—Topiramate—migraine	0.000111	0.001	CcSEcCtD
Nadolol—Hypertension—Valproic Acid—migraine	0.00011	0.000998	CcSEcCtD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.00011	0.00228	CbGpPWpGaD
Nadolol—Diarrhoea—Propranolol—migraine	0.000109	0.00099	CcSEcCtD
Nadolol—Chest pain—Valproic Acid—migraine	0.000109	0.000984	CcSEcCtD
Nadolol—Alopecia—Gabapentin—migraine	0.000107	0.000973	CcSEcCtD
Nadolol—Vision blurred—Timolol—migraine	0.000107	0.00097	CcSEcCtD
Nadolol—Agranulocytosis—Topiramate—migraine	0.000106	0.000963	CcSEcCtD
Nadolol—Dry mouth—Valproic Acid—migraine	0.000106	0.000963	CcSEcCtD
Nadolol—Dizziness—Propranolol—migraine	0.000106	0.000957	CcSEcCtD
Nadolol—Asthenia—Verapamil—migraine	0.000105	0.000955	CcSEcCtD
Nadolol—Flatulence—Gabapentin—migraine	0.000104	0.000944	CcSEcCtD
Nadolol—Oedema—Valproic Acid—migraine	0.000104	0.000944	CcSEcCtD
Nadolol—Bradycardia—Topiramate—migraine	0.000104	0.000943	CcSEcCtD
Nadolol—Pruritus—Verapamil—migraine	0.000104	0.000942	CcSEcCtD
Nadolol—ADRB3—GPCR ligand binding—HTR1B—migraine	0.000103	0.00213	CbGpPWpGaD
Nadolol—Syncope—Timolol—migraine	0.000102	0.000923	CcSEcCtD
Nadolol—Hallucination—Topiramate—migraine	0.000102	0.000922	CcSEcCtD
Nadolol—Vomiting—Propranolol—migraine	0.000102	0.00092	CcSEcCtD
Nadolol—ADRB1—GPCR ligand binding—HTR1D—migraine	0.000101	0.00209	CbGpPWpGaD
Nadolol—Hyperhidrosis—Valproic Acid—migraine	0.000101	0.000912	CcSEcCtD
Nadolol—Rash—Propranolol—migraine	0.000101	0.000912	CcSEcCtD
Nadolol—Dermatitis—Propranolol—migraine	0.000101	0.000911	CcSEcCtD
Nadolol—Diarrhoea—Verapamil—migraine	0.000101	0.000911	CcSEcCtD
Nadolol—Loss of consciousness—Timolol—migraine	9.99e-05	0.000905	CcSEcCtD
Nadolol—Vision blurred—Gabapentin—migraine	9.97e-05	0.000903	CcSEcCtD
Nadolol—Anorexia—Valproic Acid—migraine	9.93e-05	0.000899	CcSEcCtD
Nadolol—Cough—Timolol—migraine	9.92e-05	0.000898	CcSEcCtD
Nadolol—ADRB3—GPCR ligand binding—HTR1A—migraine	9.91e-05	0.00205	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—HTR1D—migraine	9.87e-05	0.00204	CbGpPWpGaD
Nadolol—Visual impairment—Topiramate—migraine	9.86e-05	0.000893	CcSEcCtD
Nadolol—Hypertension—Timolol—migraine	9.81e-05	0.000889	CcSEcCtD
Nadolol—ADRB3—GPCR ligand binding—TAC1—migraine	9.76e-05	0.00202	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—NPS—migraine	9.76e-05	0.00202	CbGpPWpGaD
Nadolol—Hypotension—Valproic Acid—migraine	9.74e-05	0.000882	CcSEcCtD
Nadolol—Dizziness—Verapamil—migraine	9.72e-05	0.00088	CcSEcCtD
Nadolol—Chest pain—Timolol—migraine	9.68e-05	0.000876	CcSEcCtD
Nadolol—ADRB3—GPCR downstream signaling—HTR1D—migraine	9.6e-05	0.00199	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—HTR2C—migraine	9.57e-05	0.00198	CbGpPWpGaD
Nadolol—Tinnitus—Topiramate—migraine	9.54e-05	0.000864	CcSEcCtD
Nadolol—Syncope—Gabapentin—migraine	9.49e-05	0.00086	CcSEcCtD
Nadolol—Nausea—Propranolol—migraine	9.49e-05	0.000859	CcSEcCtD
Nadolol—Dry mouth—Timolol—migraine	9.46e-05	0.000857	CcSEcCtD
Nadolol—Insomnia—Valproic Acid—migraine	9.42e-05	0.000853	CcSEcCtD
Nadolol—ADRB1—GPCR ligand binding—HTR2B—migraine	9.38e-05	0.00194	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	9.37e-05	0.00194	CbGpPWpGaD
Nadolol—Paraesthesia—Valproic Acid—migraine	9.36e-05	0.000847	CcSEcCtD
Nadolol—Vomiting—Verapamil—migraine	9.34e-05	0.000846	CcSEcCtD
Nadolol—ADRB3—GPCR ligand binding—EDNRA—migraine	9.31e-05	0.00193	CbGpPWpGaD
Nadolol—Loss of consciousness—Gabapentin—migraine	9.3e-05	0.000842	CcSEcCtD
Nadolol—Dyspnoea—Valproic Acid—migraine	9.29e-05	0.000841	CcSEcCtD
Nadolol—Oedema—Timolol—migraine	9.28e-05	0.00084	CcSEcCtD
Nadolol—Rash—Verapamil—migraine	9.27e-05	0.000839	CcSEcCtD
Nadolol—Dermatitis—Verapamil—migraine	9.26e-05	0.000838	CcSEcCtD
Nadolol—Cough—Gabapentin—migraine	9.24e-05	0.000836	CcSEcCtD
Nadolol—Dyspepsia—Valproic Acid—migraine	9.17e-05	0.000831	CcSEcCtD
Nadolol—ADRB2—GPCR ligand binding—HTR2B—migraine	9.17e-05	0.0019	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	9.16e-05	0.00189	CbGpPWpGaD
Nadolol—Hypertension—Gabapentin—migraine	9.14e-05	0.000827	CcSEcCtD
Nadolol—Shock—Timolol—migraine	9.13e-05	0.000826	CcSEcCtD
Nadolol—Decreased appetite—Valproic Acid—migraine	9.06e-05	0.00082	CcSEcCtD
Nadolol—Alopecia—Topiramate—migraine	9.04e-05	0.000819	CcSEcCtD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	9.02e-05	0.00186	CbGpPWpGaD
Nadolol—Chest pain—Gabapentin—migraine	9.01e-05	0.000816	CcSEcCtD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	9e-05	0.00186	CbGpPWpGaD
Nadolol—Fatigue—Valproic Acid—migraine	8.98e-05	0.000813	CcSEcCtD
Nadolol—Hyperhidrosis—Timolol—migraine	8.97e-05	0.000812	CcSEcCtD
Nadolol—ADRB3—GPCR ligand binding—CALCA—migraine	8.96e-05	0.00185	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—HTR2B—migraine	8.93e-05	0.00185	CbGpPWpGaD
Nadolol—Constipation—Valproic Acid—migraine	8.91e-05	0.000807	CcSEcCtD
Nadolol—Pain—Valproic Acid—migraine	8.91e-05	0.000807	CcSEcCtD
Nadolol—Anorexia—Timolol—migraine	8.84e-05	0.000801	CcSEcCtD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	8.82e-05	0.00182	CbGpPWpGaD
Nadolol—Dry mouth—Gabapentin—migraine	8.81e-05	0.000798	CcSEcCtD
Nadolol—Flatulence—Topiramate—migraine	8.77e-05	0.000795	CcSEcCtD
Nadolol—Nausea—Verapamil—migraine	8.73e-05	0.00079	CcSEcCtD
Nadolol—ADRB3—Signaling by GPCR—HTR1D—migraine	8.72e-05	0.0018	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	8.71e-05	0.0018	CbGpPWpGaD
Nadolol—Hypotension—Timolol—migraine	8.67e-05	0.000785	CcSEcCtD
Nadolol—Oedema—Gabapentin—migraine	8.64e-05	0.000782	CcSEcCtD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	8.52e-05	0.00176	CbGpPWpGaD
Nadolol—Shock—Gabapentin—migraine	8.5e-05	0.00077	CcSEcCtD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	8.47e-05	0.00175	CbGpPWpGaD
Nadolol—Vision blurred—Topiramate—migraine	8.39e-05	0.00076	CcSEcCtD
Nadolol—Insomnia—Timolol—migraine	8.39e-05	0.00076	CcSEcCtD
Nadolol—ADRB3—GPCR ligand binding—HTR7—migraine	8.38e-05	0.00173	CbGpPWpGaD
Nadolol—Hyperhidrosis—Gabapentin—migraine	8.35e-05	0.000756	CcSEcCtD
Nadolol—Paraesthesia—Timolol—migraine	8.33e-05	0.000754	CcSEcCtD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	8.29e-05	0.00171	CbGpPWpGaD
Nadolol—Dyspnoea—Timolol—migraine	8.27e-05	0.000749	CcSEcCtD
Nadolol—Body temperature increased—Valproic Acid—migraine	8.24e-05	0.000746	CcSEcCtD
Nadolol—Anorexia—Gabapentin—migraine	8.23e-05	0.000746	CcSEcCtD
Nadolol—Dyspepsia—Timolol—migraine	8.17e-05	0.000739	CcSEcCtD
Nadolol—ADRB3—Signaling by GPCR—HTR2B—migraine	8.11e-05	0.00168	CbGpPWpGaD
Nadolol—Hypotension—Gabapentin—migraine	8.07e-05	0.000731	CcSEcCtD
Nadolol—Decreased appetite—Timolol—migraine	8.06e-05	0.00073	CcSEcCtD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	8.02e-05	0.00166	CbGpPWpGaD
Nadolol—Fatigue—Timolol—migraine	8e-05	0.000724	CcSEcCtD
Nadolol—Syncope—Topiramate—migraine	7.99e-05	0.000723	CcSEcCtD
Nadolol—Pain—Timolol—migraine	7.93e-05	0.000718	CcSEcCtD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	7.85e-05	0.00162	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CALCRL—migraine	7.84e-05	0.00162	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—RAMP1—migraine	7.84e-05	0.00162	CbGpPWpGaD
Nadolol—Loss of consciousness—Topiramate—migraine	7.83e-05	0.000709	CcSEcCtD
Nadolol—Insomnia—Gabapentin—migraine	7.81e-05	0.000707	CcSEcCtD
Nadolol—Cough—Topiramate—migraine	7.77e-05	0.000704	CcSEcCtD
Nadolol—Paraesthesia—Gabapentin—migraine	7.76e-05	0.000702	CcSEcCtD
Nadolol—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	7.73e-05	0.0016	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	7.72e-05	0.0016	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	7.71e-05	0.00159	CbGpPWpGaD
Nadolol—Dyspnoea—Gabapentin—migraine	7.7e-05	0.000697	CcSEcCtD
Nadolol—Hypertension—Topiramate—migraine	7.69e-05	0.000696	CcSEcCtD
Nadolol—ADRB2—GPCR downstream signaling—CALCRL—migraine	7.67e-05	0.00159	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—RAMP1—migraine	7.67e-05	0.00159	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	7.63e-05	0.00158	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	7.61e-05	0.00157	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	7.61e-05	0.00157	CbGpPWpGaD
Nadolol—Dyspepsia—Gabapentin—migraine	7.6e-05	0.000689	CcSEcCtD
Nadolol—Chest pain—Topiramate—migraine	7.58e-05	0.000686	CcSEcCtD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	7.56e-05	0.00156	CbGpPWpGaD
Nadolol—Decreased appetite—Gabapentin—migraine	7.51e-05	0.00068	CcSEcCtD
Nadolol—Asthenia—Valproic Acid—migraine	7.48e-05	0.000677	CcSEcCtD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	7.46e-05	0.00154	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	7.46e-05	0.00154	CbGpPWpGaD
Nadolol—Fatigue—Gabapentin—migraine	7.45e-05	0.000674	CcSEcCtD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	7.44e-05	0.00154	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	7.44e-05	0.00154	CbGpPWpGaD
Nadolol—Dry mouth—Topiramate—migraine	7.41e-05	0.000671	CcSEcCtD
Nadolol—Constipation—Gabapentin—migraine	7.39e-05	0.000669	CcSEcCtD
Nadolol—Pain—Gabapentin—migraine	7.39e-05	0.000669	CcSEcCtD
Nadolol—Pruritus—Valproic Acid—migraine	7.37e-05	0.000668	CcSEcCtD
Nadolol—Body temperature increased—Timolol—migraine	7.33e-05	0.000664	CcSEcCtD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	7.3e-05	0.00151	CbGpPWpGaD
Nadolol—Oedema—Topiramate—migraine	7.27e-05	0.000658	CcSEcCtD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	7.26e-05	0.0015	CbGpPWpGaD
Nadolol—Shock—Topiramate—migraine	7.15e-05	0.000647	CcSEcCtD
Nadolol—Diarrhoea—Valproic Acid—migraine	7.13e-05	0.000646	CcSEcCtD
Nadolol—ADRB1—Signaling by GPCR—RAMP1—migraine	7.12e-05	0.00147	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CALCRL—migraine	7.12e-05	0.00147	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	7.1e-05	0.00147	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CALCRL—migraine	7.09e-05	0.00147	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—RAMP1—migraine	7.09e-05	0.00147	CbGpPWpGaD
Nadolol—Hyperhidrosis—Topiramate—migraine	7.03e-05	0.000636	CcSEcCtD
Nadolol—ADRB2—Signaling by GPCR—CALCRL—migraine	6.97e-05	0.00144	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—RAMP1—migraine	6.97e-05	0.00144	CbGpPWpGaD
Nadolol—Anorexia—Topiramate—migraine	6.93e-05	0.000627	CcSEcCtD
Nadolol—Dizziness—Valproic Acid—migraine	6.89e-05	0.000624	CcSEcCtD
Nadolol—Body temperature increased—Gabapentin—migraine	6.83e-05	0.000618	CcSEcCtD
Nadolol—Hypotension—Topiramate—migraine	6.79e-05	0.000615	CcSEcCtD
Nadolol—Asthenia—Timolol—migraine	6.66e-05	0.000603	CcSEcCtD
Nadolol—Vomiting—Valproic Acid—migraine	6.63e-05	0.0006	CcSEcCtD
Nadolol—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	6.61e-05	0.00137	CbGpPWpGaD
Nadolol—Insomnia—Topiramate—migraine	6.57e-05	0.000595	CcSEcCtD
Nadolol—Rash—Valproic Acid—migraine	6.57e-05	0.000595	CcSEcCtD
Nadolol—Dermatitis—Valproic Acid—migraine	6.56e-05	0.000594	CcSEcCtD
Nadolol—Pruritus—Timolol—migraine	6.56e-05	0.000594	CcSEcCtD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	6.53e-05	0.00135	CbGpPWpGaD
Nadolol—Paraesthesia—Topiramate—migraine	6.53e-05	0.000591	CcSEcCtD
Nadolol—Dyspnoea—Topiramate—migraine	6.48e-05	0.000587	CcSEcCtD
Nadolol—Dyspepsia—Topiramate—migraine	6.4e-05	0.000579	CcSEcCtD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	6.39e-05	0.00132	CbGpPWpGaD
Nadolol—Diarrhoea—Timolol—migraine	6.35e-05	0.000575	CcSEcCtD
Nadolol—Decreased appetite—Topiramate—migraine	6.32e-05	0.000572	CcSEcCtD
Nadolol—Fatigue—Topiramate—migraine	6.27e-05	0.000567	CcSEcCtD
Nadolol—Pain—Topiramate—migraine	6.21e-05	0.000563	CcSEcCtD
Nadolol—Constipation—Topiramate—migraine	6.21e-05	0.000563	CcSEcCtD
Nadolol—Asthenia—Gabapentin—migraine	6.2e-05	0.000561	CcSEcCtD
Nadolol—Nausea—Valproic Acid—migraine	6.19e-05	0.00056	CcSEcCtD
Nadolol—Dizziness—Timolol—migraine	6.13e-05	0.000555	CcSEcCtD
Nadolol—Pruritus—Gabapentin—migraine	6.11e-05	0.000553	CcSEcCtD
Nadolol—ADRB1—GPCR ligand binding—HTR1B—migraine	6.11e-05	0.00126	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—HTR1B—migraine	5.98e-05	0.00124	CbGpPWpGaD
Nadolol—Diarrhoea—Gabapentin—migraine	5.91e-05	0.000535	CcSEcCtD
Nadolol—Vomiting—Timolol—migraine	5.9e-05	0.000534	CcSEcCtD
Nadolol—ADRB1—GPCR ligand binding—HTR1A—migraine	5.88e-05	0.00122	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—HTR2A—migraine	5.87e-05	0.00121	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	5.86e-05	0.00121	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	5.86e-05	0.00121	CbGpPWpGaD
Nadolol—Rash—Timolol—migraine	5.85e-05	0.00053	CcSEcCtD
Nadolol—Dermatitis—Timolol—migraine	5.84e-05	0.000529	CcSEcCtD
Nadolol—ADRB3—GPCR downstream signaling—HTR1B—migraine	5.82e-05	0.0012	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—NPS—migraine	5.79e-05	0.0012	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—TAC1—migraine	5.79e-05	0.0012	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—HTR1A—migraine	5.75e-05	0.00119	CbGpPWpGaD
Nadolol—Body temperature increased—Topiramate—migraine	5.74e-05	0.00052	CcSEcCtD
Nadolol—Dizziness—Gabapentin—migraine	5.71e-05	0.000517	CcSEcCtD
Nadolol—ADRB1—GPCR downstream signaling—HTR1D—migraine	5.7e-05	0.00118	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—HTR2C—migraine	5.68e-05	0.00117	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—NPS—migraine	5.67e-05	0.00117	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—TAC1—migraine	5.67e-05	0.00117	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—HTR1A—migraine	5.6e-05	0.00116	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HTR1D—migraine	5.58e-05	0.00115	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—HTR2C—migraine	5.56e-05	0.00115	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—EDNRA—migraine	5.53e-05	0.00114	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—TAC1—migraine	5.52e-05	0.00114	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—NPS—migraine	5.52e-05	0.00114	CbGpPWpGaD
Nadolol—Nausea—Timolol—migraine	5.51e-05	0.000499	CcSEcCtD
Nadolol—Vomiting—Gabapentin—migraine	5.49e-05	0.000497	CcSEcCtD
Nadolol—Rash—Gabapentin—migraine	5.45e-05	0.000493	CcSEcCtD
Nadolol—Dermatitis—Gabapentin—migraine	5.44e-05	0.000493	CcSEcCtD
Nadolol—ADRB3—GPCR downstream signaling—HTR2C—migraine	5.41e-05	0.00112	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—EDNRA—migraine	5.41e-05	0.00112	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.34e-05	0.0011	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CALCA—migraine	5.32e-05	0.0011	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—HTR2B—migraine	5.3e-05	0.0011	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—HTR1B—migraine	5.28e-05	0.00109	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—EDNRA—migraine	5.26e-05	0.00109	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.22e-05	0.00108	CbGpPWpGaD
Nadolol—Asthenia—Topiramate—migraine	5.21e-05	0.000472	CcSEcCtD
Nadolol—ADRB2—GPCR ligand binding—CALCA—migraine	5.2e-05	0.00108	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HTR2B—migraine	5.18e-05	0.00107	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HTR1D—migraine	5.18e-05	0.00107	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HTR1D—migraine	5.15e-05	0.00107	CbGpPWpGaD
Nadolol—Pruritus—Topiramate—migraine	5.14e-05	0.000466	CcSEcCtD
Nadolol—Nausea—Gabapentin—migraine	5.13e-05	0.000465	CcSEcCtD
Nadolol—ADRB3—Signaling by GPCR—HTR1A—migraine	5.09e-05	0.00105	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CALCA—migraine	5.06e-05	0.00105	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HTR1D—migraine	5.06e-05	0.00105	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—TAC1—migraine	5.01e-05	0.00104	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—NPS—migraine	5.01e-05	0.00104	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	4.98e-05	0.00103	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—HTR7—migraine	4.98e-05	0.00103	CbGpPWpGaD
Nadolol—Diarrhoea—Topiramate—migraine	4.97e-05	0.00045	CcSEcCtD
Nadolol—ADRB3—Signaling by GPCR—HTR2C—migraine	4.91e-05	0.00102	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—HTR7—migraine	4.87e-05	0.00101	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HTR2B—migraine	4.81e-05	0.000995	CbGpPWpGaD
Nadolol—Dizziness—Topiramate—migraine	4.81e-05	0.000435	CcSEcCtD
Nadolol—ADRB3—Signaling Pathways—HTR2B—migraine	4.79e-05	0.00099	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—EDNRA—migraine	4.78e-05	0.000988	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—HTR7—migraine	4.74e-05	0.00098	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HTR2B—migraine	4.71e-05	0.000973	CbGpPWpGaD
Nadolol—Vomiting—Topiramate—migraine	4.62e-05	0.000418	CcSEcCtD
Nadolol—ADRB3—Signaling by GPCR—CALCA—migraine	4.6e-05	0.000951	CbGpPWpGaD
Nadolol—Rash—Topiramate—migraine	4.58e-05	0.000415	CcSEcCtD
Nadolol—Dermatitis—Topiramate—migraine	4.58e-05	0.000415	CcSEcCtD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.58e-05	0.000946	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.48e-05	0.000926	CbGpPWpGaD
Nadolol—Nausea—Topiramate—migraine	4.32e-05	0.000391	CcSEcCtD
Nadolol—ADRB3—Signaling by GPCR—HTR7—migraine	4.3e-05	0.00089	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—LRP1—migraine	4.22e-05	0.000872	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—RAMP1—migraine	4.21e-05	0.00087	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CALCRL—migraine	4.21e-05	0.00087	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	4.18e-05	0.000865	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CALCRL—migraine	4.12e-05	0.000851	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—RAMP1—migraine	4.12e-05	0.000851	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—HTR2A—migraine	3.48e-05	0.000721	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—HTR1B—migraine	3.45e-05	0.000714	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—HTR2A—migraine	3.41e-05	0.000705	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HTR1B—migraine	3.38e-05	0.000699	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—HTR1A—migraine	3.32e-05	0.000687	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—HTR2A—migraine	3.32e-05	0.000686	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—TAC1—migraine	3.27e-05	0.000677	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—NPS—migraine	3.27e-05	0.000677	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HTR1A—migraine	3.25e-05	0.000672	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NOTCH4—migraine	3.23e-05	0.000669	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—HTR2C—migraine	3.21e-05	0.000664	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—NPS—migraine	3.2e-05	0.000662	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—TAC1—migraine	3.2e-05	0.000662	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HTR2C—migraine	3.14e-05	0.000649	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HTR1B—migraine	3.14e-05	0.000649	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	3.13e-05	0.000648	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—EDNRA—migraine	3.12e-05	0.000646	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HTR1B—migraine	3.12e-05	0.000645	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—TNF—migraine	3.08e-05	0.000637	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HTR1B—migraine	3.07e-05	0.000634	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR1D—migraine	3.06e-05	0.000632	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—EDNRA—migraine	3.05e-05	0.000632	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HTR1A—migraine	3.02e-05	0.000624	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—HTR2A—migraine	3.01e-05	0.000623	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CALCA—migraine	3.01e-05	0.000622	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HTR1A—migraine	3e-05	0.000621	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR1D—migraine	2.99e-05	0.000619	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—NPS—migraine	2.97e-05	0.000615	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—TAC1—migraine	2.97e-05	0.000615	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NPS—migraine	2.96e-05	0.000612	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—PGR—migraine	2.96e-05	0.000612	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—TAC1—migraine	2.96e-05	0.000612	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HTR1A—migraine	2.95e-05	0.000611	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CALCA—migraine	2.94e-05	0.000608	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HTR2C—migraine	2.92e-05	0.000603	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—NPS—migraine	2.91e-05	0.000601	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—TAC1—migraine	2.91e-05	0.000601	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HTR2C—migraine	2.9e-05	0.0006	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HTR2C—migraine	2.85e-05	0.00059	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR2B—migraine	2.84e-05	0.000588	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—EDNRA—migraine	2.84e-05	0.000587	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—EDNRA—migraine	2.82e-05	0.000584	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—HTR7—migraine	2.81e-05	0.000582	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR2B—migraine	2.78e-05	0.000575	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—EDNRA—migraine	2.77e-05	0.000574	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NOTCH3—migraine	2.75e-05	0.000569	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HTR7—migraine	2.75e-05	0.000569	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CALCA—migraine	2.73e-05	0.000565	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CALCA—migraine	2.72e-05	0.000562	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CALCA—migraine	2.67e-05	0.000552	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HTR7—migraine	2.55e-05	0.000528	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HTR7—migraine	2.54e-05	0.000526	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—LRP1—migraine	2.5e-05	0.000518	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HTR7—migraine	2.5e-05	0.000517	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—LRP1—migraine	2.45e-05	0.000506	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—TGFBR2—migraine	2.19e-05	0.000453	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CACNA1A—migraine	1.98e-05	0.00041	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—HTR2A—migraine	1.97e-05	0.000407	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HTR2A—migraine	1.93e-05	0.000398	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NOTCH4—migraine	1.92e-05	0.000397	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NOTCH4—migraine	1.88e-05	0.000388	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR1B—migraine	1.85e-05	0.000383	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR1B—migraine	1.81e-05	0.000375	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HTR2A—migraine	1.79e-05	0.00037	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR1A—migraine	1.78e-05	0.000369	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HTR2A—migraine	1.78e-05	0.000368	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NPS—migraine	1.76e-05	0.000363	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TAC1—migraine	1.76e-05	0.000363	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PGR—migraine	1.76e-05	0.000363	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HTR2A—migraine	1.75e-05	0.000362	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR1A—migraine	1.74e-05	0.000361	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR2C—migraine	1.72e-05	0.000356	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TAC1—migraine	1.72e-05	0.000355	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NPS—migraine	1.72e-05	0.000355	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PGR—migraine	1.72e-05	0.000355	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR2C—migraine	1.68e-05	0.000348	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—EDNRA—migraine	1.68e-05	0.000346	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—EDNRA—migraine	1.64e-05	0.000339	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NOTCH3—migraine	1.63e-05	0.000338	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CALCA—migraine	1.61e-05	0.000334	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NOTCH3—migraine	1.6e-05	0.00033	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—ESR1—migraine	1.58e-05	0.000327	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CALCA—migraine	1.58e-05	0.000326	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.52e-05	0.000314	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR7—migraine	1.51e-05	0.000312	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR7—migraine	1.48e-05	0.000305	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TGFBR2—migraine	1.3e-05	0.000269	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TGFBR2—migraine	1.27e-05	0.000263	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR2A—migraine	1.06e-05	0.000218	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR2A—migraine	1.03e-05	0.000214	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ESR1—migraine	9.38e-06	0.000194	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ESR1—migraine	9.17e-06	0.00019	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—MTHFR—migraine	6.56e-06	0.000136	CbGpPWpGaD
